USANA HEALTH SCIENCES, INC. Operating Cash Flow
USANA HEALTH SCIENCES, INC. (USNA) reported Operating Cash Flow of $33.08 million for the 6-month period ending 2026-07-04, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-07-04 was $23.32M, a 90.86% increase year-over-year.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-04-04 was $9.76M, a 36.97% decline year-over-year.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-01-03 was -$3.39M, a 158.60% decline year-over-year.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-27 was -$1.96M, a 106.64% decline year-over-year.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2026 was $22.35M, a 63.36% decline from fiscal 2024.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2024 was $60.99M, a 13.66% decline from fiscal 2023.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2023 was $70.64M, a 32.01% decline from fiscal 2022.
- USANA HEALTH SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2022 was $103.90M, a 14.29% decline from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-07-04 | $23.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $33.08M 10-Q · filed 2026-08-13 | $29.69M derived: sum of 3 quarters · filed 2026-08-13 | $27.73M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-04-04 | $9.76M 10-Q · filed 2026-05-12 | $6.37M derived: sum of 2 quarters · filed 2026-05-12 | $4.41M derived: sum of 3 quarters · filed 2026-05-12 | $16.63M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-01-03 | -$3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$5.35M derived: sum of 2 quarters · filed 2026-03-16 | $6.87M derived: sum of 3 quarters · filed 2026-08-13 | $22.35M 10-K · filed 2026-03-16 | |
| 2025-09-27 | -$1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $10.26M derived: sum of 2 quarters · filed 2026-08-13 | $25.74M 10-Q · filed 2025-11-05 | $31.52M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-28 | $12.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $27.70M 10-Q · filed 2026-08-13 | $33.48M derived: sum of 3 quarters · filed 2026-08-13 | $63.02M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-29 | $15.48M 10-Q · filed 2026-05-12 | $21.27M derived: sum of 2 quarters · filed 2026-05-12 | $50.80M derived: sum of 3 quarters · filed 2026-05-12 | $58.79M derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-28 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $35.32M derived: sum of 2 quarters · filed 2026-03-16 | $43.31M derived: sum of 3 quarters · filed 2026-03-16 | $60.99M 10-K · filed 2026-03-16 | |
| 2024-09-28 | $29.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $37.52M derived: sum of 2 quarters · filed 2025-11-05 | $55.21M 10-Q · filed 2025-11-05 | $81.23M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-06-29 | $7.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $25.67M 10-Q · filed 2025-08-05 | $51.70M derived: sum of 3 quarters · filed 2026-03-16 | $73.93M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-03-30 | $17.68M 10-Q · filed 2025-05-06 | $43.71M derived: sum of 2 quarters · filed 2026-03-16 | $65.94M derived: sum of 3 quarters · filed 2026-03-16 | $75.49M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2023-12-30 | $26.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $48.26M derived: sum of 2 quarters · filed 2026-03-16 | $57.81M derived: sum of 3 quarters · filed 2026-03-16 | $70.64M 10-K · filed 2026-03-16 | |
| 2023-09-30 | $22.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $31.79M derived: sum of 2 quarters · filed 2024-11-05 | $44.62M 10-Q · filed 2024-11-05 | $85.08M derived: sum of 4 quarters · filed 2025-03-12 | |
| 2023-07-01 | $9.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $22.38M 10-Q · filed 2024-08-06 | $62.85M derived: sum of 3 quarters · filed 2025-03-12 | $91.97M derived: sum of 4 quarters · filed 2025-03-12 | |
| 2023-04-01 | $12.83M 10-Q · filed 2024-05-07 | $53.30M derived: sum of 2 quarters · filed 2025-03-12 | $82.42M derived: sum of 3 quarters · filed 2025-03-12 | $97.03M derived: sum of 4 quarters · filed 2025-03-12 | |
| 2022-12-31 | $40.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $69.59M derived: sum of 2 quarters · filed 2025-03-12 | $84.20M derived: sum of 3 quarters · filed 2025-03-12 | $103.90M 10-K · filed 2025-03-12 | |
| 2022-10-01 | $29.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $43.74M derived: sum of 2 quarters · filed 2023-11-07 | $63.44M 10-Q · filed 2023-11-07 | $88.36M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-07-02 | $14.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $34.31M 10-Q · filed 2023-08-08 | $59.24M derived: sum of 3 quarters · filed 2024-02-27 | $96.72M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-04-02 | $19.70M 10-Q · filed 2023-05-09 | $44.62M derived: sum of 2 quarters · filed 2024-02-27 | $82.11M derived: sum of 3 quarters · filed 2024-02-27 | $121.27M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-01-01 | $24.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $62.41M derived: sum of 2 quarters · filed 2024-02-27 | $101.57M derived: sum of 3 quarters · filed 2024-02-27 | $121.23M 10-K · filed 2024-02-27 | |
| 2021-10-02 | $37.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $76.65M derived: sum of 2 quarters · filed 2022-11-08 | $96.31M 10-Q · filed 2022-11-08 | $144.22M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-07-03 | $39.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $58.82M 10-Q · filed 2022-08-09 | $106.73M derived: sum of 3 quarters · filed 2023-02-28 | $155.79M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-04-03 | $19.66M 10-Q · filed 2022-05-11 | $67.57M derived: sum of 2 quarters · filed 2023-02-28 | $116.64M derived: sum of 3 quarters · filed 2023-02-28 | $149.27M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-01-02 | $47.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $96.98M derived: sum of 2 quarters · filed 2023-02-28 | $129.62M derived: sum of 3 quarters · filed 2023-02-28 | $160.40M 10-K · filed 2023-02-28 | |
| 2020-09-26 | $49.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $81.70M derived: sum of 2 quarters · filed 2021-11-10 | $112.49M 10-Q · filed 2021-11-10 | $168.23M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-27 | $32.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $63.42M 10-Q · filed 2021-08-11 | $119.16M derived: sum of 3 quarters · filed 2022-03-01 | $169.48M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-28 | $30.79M 10-Q · filed 2021-05-11 | $86.53M derived: sum of 2 quarters · filed 2022-03-01 | $136.84M derived: sum of 3 quarters · filed 2022-03-01 | $152.00M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-28 | $55.74M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $106.05M derived: sum of 2 quarters · filed 2022-03-01 | $121.21M derived: sum of 3 quarters · filed 2022-03-01 | $126.73M 10-K · filed 2022-03-01 | |
| 2019-09-28 | $50.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $65.47M derived: sum of 2 quarters · filed 2020-11-03 | $70.99M 10-Q · filed 2020-11-03 | $111.42M derived: sum of 4 quarters · filed 2021-03-02 | |
| 2019-06-29 | $15.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $20.68M 10-Q · filed 2020-08-04 | $61.10M derived: sum of 3 quarters · filed 2021-03-02 | $115.61M derived: sum of 4 quarters · filed 2021-03-02 | |
| 2019-03-30 | $5.52M 10-Q · filed 2020-05-05 | $45.95M derived: sum of 2 quarters · filed 2021-03-02 | $100.45M derived: sum of 3 quarters · filed 2021-03-02 | $138.12M derived: sum of 4 quarters · filed 2021-03-02 | |
| 2018-12-29 | $40.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $94.93M derived: sum of 2 quarters · filed 2021-03-02 | $132.60M derived: sum of 3 quarters · filed 2021-03-02 | $152.12M 10-K · filed 2021-03-02 | |
| 2018-09-29 | $54.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $92.17M derived: sum of 2 quarters · filed 2019-11-05 | $111.69M 10-Q · filed 2019-11-05 | $166.83M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | $37.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $57.19M 10-Q · filed 2019-08-06 | $112.33M derived: sum of 3 quarters · filed 2020-02-25 | $125.36M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-31 | $19.52M 10-Q · filed 2019-05-07 | $74.65M derived: sum of 2 quarters · filed 2020-02-25 | $87.69M derived: sum of 3 quarters · filed 2020-02-25 | $141.39M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2017-12-30 | $55.13M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $68.17M derived: sum of 2 quarters · filed 2020-02-25 | $121.87M derived: sum of 3 quarters · filed 2020-02-25 | $123.77M 10-K · filed 2020-02-25 | $123.78M 10-K · filed 2018-02-28 |
| 2017-09-30 | $13.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $66.74M derived: sum of 2 quarters · filed 2018-11-07 | $68.64M 10-Q · filed 2018-11-07 | ||
| 2017-07-01 | $53.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $55.60M 10-Q · filed 2018-08-08 | |||
| 2017-04-01 | $1.90M 10-Q · filed 2018-05-09 | ||||
| 2016-12-31 | $136.89M 10-K · filed 2019-02-26 | $137.03M 10-K · filed 2018-02-28 | |||
| 2016-01-02 | $111.47M 10-K · filed 2018-02-28 | ||||
| 2015-01-03 | $105.19M 10-K · filed 2015-03-17 | ||||
| 2014-06-28 | $28.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $31.25M 10-Q · filed 2014-08-05 | $65.55M derived: sum of 3 quarters · filed 2015-03-17 | $82.85M derived: sum of 4 quarters · filed 2015-03-17 | |
| 2014-03-29 | $2.47M 10-Q · filed 2014-05-07 | $36.77M derived: sum of 2 quarters · filed 2015-03-17 | $54.07M derived: sum of 3 quarters · filed 2015-03-17 | $81.06M derived: sum of 4 quarters · filed 2015-03-17 | |
| 2013-12-28 | $34.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | $51.60M derived: sum of 2 quarters · filed 2015-03-17 | $78.59M derived: sum of 3 quarters · filed 2015-03-17 | $98.89M 10-K · filed 2015-03-17 | |
| 2013-09-28 | $17.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $44.29M derived: sum of 2 quarters · filed 2014-08-05 | $64.59M 10-Q · filed 2013-11-07 | $93.78M derived: sum of 4 quarters · filed 2015-03-17 | |
| 2013-06-29 | $26.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $47.30M 10-Q · filed 2014-08-05 | $76.48M derived: sum of 3 quarters · filed 2015-03-17 | $96.16M derived: sum of 4 quarters · filed 2015-03-17 | |
| 2013-03-30 | $20.30M 10-Q · filed 2014-05-07 | $49.49M derived: sum of 2 quarters · filed 2015-03-17 | $69.16M derived: sum of 3 quarters · filed 2015-03-17 | $90.47M derived: sum of 4 quarters · filed 2015-03-17 | |
| 2012-12-29 | $29.18M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | $48.86M derived: sum of 2 quarters · filed 2015-03-17 | $70.16M derived: sum of 3 quarters · filed 2015-03-17 | $92.81M 10-K · filed 2015-03-17 | |
| 2012-09-29 | $19.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $40.98M derived: sum of 2 quarters · filed 2013-11-07 | $63.62M 10-Q · filed 2013-11-07 | $80.26M derived: sum of 4 quarters · filed 2014-03-13 | |
| 2012-06-30 | $21.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $43.95M 10-Q · filed 2013-08-08 | $60.59M derived: sum of 3 quarters · filed 2014-03-13 | $82.65M derived: sum of 4 quarters · filed 2014-03-13 | |
| 2012-03-31 | $22.64M 10-Q · filed 2013-05-07 | $39.28M derived: sum of 2 quarters · filed 2014-03-13 | $61.35M derived: sum of 3 quarters · filed 2014-03-13 | $75.21M derived: sum of 4 quarters · filed 2014-03-13 | |
| 2011-12-31 | $16.64M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $38.71M derived: sum of 2 quarters · filed 2014-03-13 | $52.56M derived: sum of 3 quarters · filed 2014-03-13 | $70.11M 10-K · filed 2014-03-13 | |
| 2011-10-01 | $22.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $35.92M derived: sum of 2 quarters · filed 2012-11-07 | $53.47M 10-Q · filed 2012-11-07 | $73.34M derived: sum of 4 quarters · filed 2013-03-11 | |
| 2011-07-02 | $13.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $31.40M 10-Q · filed 2012-08-08 | $51.27M derived: sum of 3 quarters · filed 2013-03-11 | $72.18M derived: sum of 4 quarters · filed 2013-03-11 | |
| 2011-04-02 | $17.55M 10-Q · filed 2012-05-10 | $37.41M derived: sum of 2 quarters · filed 2013-03-11 | $58.33M derived: sum of 3 quarters · filed 2013-03-11 | ||
| 2011-01-01 | $19.87M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $40.78M derived: sum of 2 quarters · filed 2013-03-11 | $66.11M 10-K · filed 2013-03-11 | ||
| 2010-10-02 | $20.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $46.24M 10-Q · filed 2011-11-09 | |||
| 2010-07-03 | $25.33M 10-Q · filed 2011-08-10 | ||||
| 2010-01-02 | $32.47M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |